Novel idebenone analogs block Shc’s access to insulin receptor to improve insulin sensitivity
出版年份 2020 全文链接
标题
Novel idebenone analogs block Shc’s access to insulin receptor to improve insulin sensitivity
作者
关键词
Drug discovery, Novel insulin sensitizing agents, Type 2 Diabetes, Shc blockers, Small molecule therapeutics
出版物
BIOMEDICINE & PHARMACOTHERAPY
Volume 132, Issue -, Pages 110823
出版商
Elsevier BV
发表日期
2020-10-10
DOI
10.1016/j.biopha.2020.110823
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of different diets used in diet-induced obesity models on insulin resistance and vascular dysfunction in C57BL/6 mice
- (2019) Philipp Lang et al. Scientific Reports
- The idebenone metabolite QS10 restores electron transfer in complex I and coenzyme Q defects
- (2018) Valentina Giorgio et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Animal models of obesity and diabetes mellitus
- (2018) Maximilian Kleinert et al. Nature Reviews Endocrinology
- P66Shc expression in diabetic rat retina
- (2018) Ming-Hui Zhao et al. BMC Ophthalmology
- Idebenone is a cytoprotective insulin sensitizer whose mechanism is Shc inhibition
- (2018) Alexey Tomilov et al. PHARMACOLOGICAL RESEARCH
- PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes
- (2017) Moufida Ben Nasr et al. Science Translational Medicine
- Idebenone: A Review in Leber’s Hereditary Optic Neuropathy
- (2016) Katherine A. Lyseng-Williamson DRUGS
- p46Shc Inhibits Thiolase and Lipid Oxidation in Mitochondria
- (2016) Alexey Tomilov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus
- (2016) Ahlke Heydemann Journal of Diabetes Research
- p66Shc: A novel biomarker of tubular oxidative injury in patients with diabetic nephropathy
- (2016) Xiaoxuan Xu et al. Scientific Reports
- p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans
- (2015) Stefano Ciciliot et al. DIABETOLOGIA
- The rise, fall, and resurgence of immunotherapy in type 1 diabetes
- (2015) Moufida Ben Nasr et al. PHARMACOLOGICAL RESEARCH
- Administration of pioglitazone alone or with alogliptin delays diabetes onset in UCD-T2DM rats
- (2014) Bethany P Cummings et al. JOURNAL OF ENDOCRINOLOGY
- PKCδPromotes High Glucose Induced Renal Tubular Oxidative Damage via Regulating Activation and Translocation of p66Shc
- (2014) Panai Song et al. Oxidative Medicine and Cellular Longevity
- Diabetes Causes Bone Marrow Autonomic Neuropathy and Impairs Stem Cell Mobilization via Dysregulated p66Shc and Sirt1
- (2013) M. Albiero et al. DIABETES
- Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia
- (2013) J. Rosenstock et al. DIABETES OBESITY & METABOLISM
- The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 Inhibitors in Adults with Type 2 Diabetes Mellitus
- (2013) Shawn Riser Taylor et al. PHARMACOTHERAPY
- Circulating Osteogenic Precursor Cells in Type 2 Diabetes Mellitus
- (2012) J. S. Manavalan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Hyperglycemia Increases Susceptibility to Ischemic Necrosis
- (2012) D. Lévigne et al. Biomed Research International
- The effects of idebenone on mitochondrial bioenergetics
- (2011) Valentina Giorgio et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats
- (2011) B. P. Cummings et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Shc locus regulates insulin signaling and adiposity in mammals
- (2010) Alexey A. Tomilov et al. AGING CELL
- A Novel Clinically Relevant Strategy to Abrogate Autoimmunity and Regulate Alloimmunity in NOD Mice
- (2010) A. Vergani et al. DIABETES
- Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats
- (2010) B. P. Cummings et al. DIABETES
- Pharmacokinetics and metabolism of idebenone in healthy male subjects
- (2009) Michael Bodmer et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Trends in the prevalence and incidence of diabetes in the UK: 1996-2005
- (2009) E L M. Gonzalez et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Pharmacokinetic properties and metabolism of idebenone
- (2009) Klaus Kutz et al. JOURNAL OF NEUROLOGY
- Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes
- (2008) P. Fiorina et al. DIABETES
- p66Shc-generated Oxidative Signal Promotes Fat Accumulation
- (2008) Ina Berniakovich et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The incretin system and its role in type 2 diabetes mellitus
- (2008) J HOLST et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Diabetic neuropathy: Mechanisms to management
- (2008) James L. Edwards et al. PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started